Down-regulation of nuclear protein ICBP90 by p53/p21Cip1/WAF1-dependent DNA-damage checkpoint signals contributes to cell cycle arrest at G1/S transition

Genes to Cells

Volumn 9, Issue 2, 2004, Pages 131-142

  Arima, Yoshimi ^a   Hirota, Toru ^a   Bronner, Christian ^b   Mousli, Marc ^b   Fujiwara, Toshiyoshi ^c   Niwa, Shin Ichiro ^d   Ishikawa, Hiroyuki ^d   Saya, Hideyuki ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

^b INSERM   (France)

^c OKAYAMA UNIVERSITY   (Japan)

^d Link Genomics ^*  (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE; DNA; DNA TOPOISOMERASE (ATP HYDROLYSING); DNA TOPOISOMERASE (ATP HYDROLYSING) ALPHA; INVERTED CCAAT BOX BINDING PROTEIN 90; NUCLEAR PROTEIN; PROTEIN P21; PROTEIN P53; RNA; UNCLASSIFIED DRUG;

ADENOVIRUS; ARTICLE; CANCER CELL CULTURE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL PROLIFERATION; CELL TRANSFORMATION; CONTROLLED STUDY; DNA DAMAGE; DNA REPLICATION; DOWN REGULATION; ENZYME ACTIVITY; GENETIC STABILITY; GENOMICS; HUMAN; HUMAN CELL; MITOSIS INHIBITION; MONITORING; PHASE TRANSITION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN EXPRESSION; REGULATORY MECHANISM; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

AMANITINS; ANTIGENS, NEOPLASM; CAFFEINE; CCAAT-ENHANCER-BINDING PROTEINS; CYCLIN B; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; DNA DAMAGE; DNA TOPOISOMERASES, TYPE II, EUKARYOTIC; DNA-BINDING PROTEINS; DOWN-REGULATION; DOXORUBICIN; FLOW CYTOMETRY; G1 PHASE; GENE EXPRESSION; GENES, CDC; HCT116 CELLS; HELA CELLS; HISTONES; HUMANS; MICROSCOPY, FLUORESCENCE; RNA, SMALL INTERFERING; S PHASE; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR PROTEIN P53;

EID: 1542330106     PISSN: 13569597     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1356-9597.2004.00710.x     Document Type: Article

References (41)

1. Banin, S., Moyal, L., Shieh, S., et al. (1998) Enhanced phosphorylation of p53 by ATM in response to DNA damage. Science 281, 1674-1677.
2. Bonapace, I.M., Latella, L., Papait, R., et al. (2002) Np95 is regulated by E1A during mitotic reactivation of terminally differentiated cells and is essential for S phase entry. J. Cell Biol. 157, 909-914.
3. Bourdon, J.C., Deguin-Chambon, V., Lelong, J.C., et al. (1997) Further characterisation of the p53 responsive element - identification of new candidate genes for trans-activation by p53. Oncogene 14, 85-94.
4. Bunz, F., Dutriaux, A., Lengauer, C., et al. (1998) Requirement for p53 and p21 to sustain G2 arrest after DNA damage. Science 282, 1497-1501.
5. Canman, C.E., Lim, D.S., Cimprich, K.A., et al. (1998) Activation of the ATM kinase by ionizing radiation and phosphorylation of p53. Science 281, 1677-1679.
6. Chen, I.T., Smith, M.L., O'Connor, P.M. & Fornace, A.J. Jr (1995) Direct interaction of Gadd45 with PCNA and evidence for competitive interaction of Gadd45 and p21 Waf1/Cip1 with PCNA. Oncogene 11, 1931-1937.
7. el-Deiry, W.S., Kern, S.E., Pietenpol, J.A., Kinzler, K.W. & Vogelstein, B. (1992) Definition of a consensus binding site for p53. Nature Genet. 1, 45-49.
8. Duronio, R.J., O'Farrell, P.H., Xie, J.E., Brook, A. & Dyson, N. (1995) The transcription factor E2F is required for S phase during Drosophila embryogenesis. Genes Dev. 9, 1445-1455.
9. Elbashir, S.M., Harborth, J., Lendeckel, W., Yalcin, A., Weber, K. & Tuschl, T. (2001) Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411, 494-498.
10. Fujimori, A., Matsuda, Y., Takemoto, Y., et al. (1998) Cloning and mapping of Np95 gene which encodes a novel nuclear protein associated with cell proliferation. Mamm. Genome 9, 1032-1035.
11. Funk, W.D., Pak, D.T., Karas, R.H., Wright, W.E. & Shay, J.W. (1992) A transcriptionally active DNA-binding site for human p53 protein complexes. Mol. Cell. Biol. 12, 2866-2871.
12. Hartwell, L.H. & Kastan, M.B. (1994) Cell cycle control and cancer. Science 266, 1821-1828.
13. Hartwell, L.H. & Weinert, T.A. (1989) Checkpoints: controls that ensure the order of cell cycle events. Science 246, 629-634.
14. Hopfner, R., Mousli, M., Jeltsch, J.M., et al. (2000) ICBP90, a novel human CCAAT binding protein, involved in the regulation of topoisomerase IIalpha expression. Cancer Res. 60, 121-128.
15. Hopfner, R., Mousli, M., Oudet, P. & Bronner, C. (2002) Overexpression of ICBP90, a novel CCAAT-binding protein, overcomes cell contact inhibition by forcing topoisomerase II alpha expression. Anticancer Res. 22, 3165-3170.
16. Isaacs, R.J., Davies, S.L., Sandri, M.I., Redwood, C., Wells, N.J. & Hickson, I.D. (1998) Physiological regulation of eukaryotic topoisomerase II. Biochim. Biophys. Acta 1400, 121-137.
17. Jacob, S.T., Sajdel, E.M. & Munro, H.N. (1970) Specific action of alpha-amanitin on mammalian RNA polymerase protein. Nature 225, 60-62.
18. Johnson, D.G., Schwarz, J.K., Cress, W.D. & Nevins, J.R. (1993) Expression of transcription factor E2F1 induces quiescent cells to enter S phase. Nature 365, 349-352.
19. Kanegae, Y., Lee, G., Sato, Y., et al. (1995) Efficient gene activation in mammalian cells by using recombinant adenovirus expressing site-specific Cre recombinase. Nucl. Acids Res. 23, 3816-3821.
20. Kato, J., Matsushime, H., Hiebert, S.W., Ewen, M.E. & Sherr, C.J. (1993) Direct binding of cyclin D to the retinoblastoma gene product (pRb) and pRb phosphorylation by the cyclin D-dependent kinase CDK4. Genes Dev. 7, 331-342.
21. Khanna, K.K., Keating, K.E., Kozlov, S., et al. (1998) ATM associates with and phosphorylates p53: mapping the region of interaction. Nature Genet. 20, 398-400.
22. Lakin, N.D. & Jackson, S.P. (1999) Regulation of p53 in response to DNA damage. Oncogene 18, 7644-7655.
23. Lengauer, C., Kinzler, K.W. & Vogelstein, B. (1997) Genetic instability in colorectal cancers. Nature 386, 623-627.
24. Lindell, T.J., Weinberg, F., Morris, P.W., Roeder, R.G. & Rutter, W.J. (1970) Specific inhibition of nuclear RNA polymerase II by alpha-amanitin. Science 170, 447-449.
25. Luo, Y., Hurwitz, J. & Massague, J. (1995) Cell-cycle inhibition by independent CDK and PCNA binding domains in p21Cip1. Nature 375, 159-161.
26. Miura, M., Watanabe, H., Sasaki, T., Tatsumi, K. & Muto, M. (2001) Dynamic changes in subnuclear NP95 location during the cell cycle and its spatial relationship with DNA replication foci. Exp. Cell Res. 263, 202-208.
27. Miyake, H., Hanada, N., Nakamura, H., et al. (1998) Overexpression of Bcl-2 in bladder cancer cells inhibits apoptosis induced by cisplatin and adenoviral-mediated p53 gene transfer. Oncogene 16, 933-943.
28. Mousli, M., Hopfner, R., Abbady, A.Q., et al. (2003) ICBP90 belongs to a new family of proteins with an expression that is deregulated in cancer cells. Br. J. Cancer 89, 120-127.
29. Muller, H. & Helin, K. (2000) The E2F transcription factors: key regulators of cell proliferation. Biochim. Biophys. Acta 1470, M1-M12.
30. Muto, M., Kanari, Y., Kubo, E., et al. (2002) Targeted disruption of Np95 gene renders murine embryonic stem cells hypersensitive to DNA damaging agents and DNA replication blocks. J. Biol. Chem. 277, 34549-34555.
31. Nevins, J.R. (1992) E2F: a link between the Rb tumor suppressor protein and viral oncoproteins. Science 258, 424-429.
32. Nitiss, J.L., Zhou, J., Rose, A., Hsiung, Y., Gale, K.C. & Osheroff, N. (1998) The bis (naphthalimide) DMP-840 causes cytotoxicity by its action against eukaryotic topoisomerase II. Biochemistry 37, 3078-3085.
33. Paulovich, A.G., Toczyski, D.P. & Hartwell, L.H. (1997) When checkpoints fail. Cell 88, 315-321.
34. Rogakou, E.P., Boon, C., Redon, C. & Bonner, W.M. (1999) Megabase chromatin domains involved in DNA double-strand breaks in vivo. J. Cell Biol. 146, 905-916.
35. Rogakou, E.P., Pilch, D.R., Orr, A.H., Ivanova, V.S. & Bonner, W.M. (1998) DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139. J. Biol. Chem. 273, 5858-5868.
36. Sakai, A., Kikuchi, Y., Muroi, M., et al. (2003) Overexpression of NP95 mRNA by Tumor Promoters in the Promotion Phase of a Two-Stage BALB/3T3 Cell Transformation Assay. Biol. Pharm. Bull. 26, 347-351.
37. Sherr, C.J. & Roberts, J.M. (1995) Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev. 9, 1149-1163.
38. Uemura, T., Kubo, E., Kanari, Y., Ikemura, T., Tatsumi, K. & Muto, M. (2000) Temporal and spatial localization of novel nuclear protein NP95 in mitotic and meiotic cells. Cell Struct. Funct. 25, 149-159.
39. Waga, S., Hannon, G.J., Beach, D. & Stillman, B. (1994) The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA. Nature 369, 574-578.
40. Zhang, W.W., Fang, X., Branch, C.D., Mazur, W., French, B.A. & Roth, J.A. (1993) Generation and identification of recombinant adenovirus by liposome-mediated transfection and PCR analysis. Biotechniques 15, 868-872.
41. Zhou, B.B., Chaturvedi, P., Spring, K., et al. (2000) Caffeine abolishes the mammalian G (2)/M DNA damage checkpoint by inhibiting ataxia-telangiectasia-mutated kinase activity. J. Biol. Chem. 275, 10342-10348.